PTC Therapeutics Announces European Commission Returns Translarna™ Opinion to CHMP For Re-evaluation ...Middle East

PR Newswire - News
- European Commission decides against adoption of negative opinion - - Translarna authorization remains active in Europe - - 2024 revenue guidance paused - WARREN, N.J., May 20, 2024 /PRNewswire/ -- PTC Therapeutics, Inc. (NASDAQ: PTCT) announced today that the European Commission (EC)...

Hence then, the article about ptc therapeutics announces european commission returns translarna opinion to chmp for re evaluation was published today ( ) and is available on PR Newswire ( Middle East ) The editorial team at PressBee has edited and verified it, and it may have been modified, fully republished, or quoted. You can read and follow the updates of this news or article from its original source.

Read More Details
Finally We wish PressBee provided you with enough information of ( PTC Therapeutics Announces European Commission Returns Translarna™ Opinion to CHMP For Re-evaluation )

Apple Storegoogle play

Last updated :

Also on site :

Most viewed in News